Skip to content
OpenCapital
AI Tools
Earnings
Screener
Charts
Watchlist
Pricing
Connect your AI
Get started
Toggle navigation menu
BWX Technologies
BWXT
Concentration Risk %
Concentration Risk % at other companies
Identive
INVE
10.3%
+7.7pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
RF Industries
RFIL
100%
0.0pp
Weis Markets
WMK
100%
0.0pp
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Segments
By segment
See full
Government Operations
89%
-3.3%
Commercial Operations
61%
-16.4%
Other financials
Income statement
See full
Revenue
$860.2M
+26.1%
Gross profit
$197.4M
+19.5%
Operating income
$106.7M
+10.4%
Net income
$91.1M
+20.7%
EPS (diluted)
$0.99
+20.7%
Balance sheet
See full
Cash & equivalents
$520.3M
+740%
Total debt
$2.0B
+68.5%
Total equity
$1.3B
+16.4%
Total assets
$4.3B
+41.6%
Cash flow
See full
Operating cash flow
$92.6M
+82.8%
CapEx
$42.5M
+27.4%
Free cash flow
$50.1M
+190%
Valuation
See full
Market cap
$16.23B
+29.3%
Enterprise value
$17.73B
+26.3%
P/E
47.1×
+4.5×
P/S
4.8×
+0.4×
Profitability
See full
Gross margin
22.7%
-1.5pp
Operating margin
12.3%
-1.5pp
Net margin
10.2%
-0.2pp
FCF margin
9.7%
-0.2pp
Returns & leverage
See full
Return on equity
28.9%
+0.7pp
Debt / equity
1.6×
+0.5×
Current ratio
2.4×
+0.4×